 Adenylyl Cyclases
"Adenylyl Cyclases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enzymes of the lyase class that catalyze the formation of CYCLIC AMP and pyrophosphate from ATP.
| Descriptor ID |
D000262
|
| MeSH Number(s) |
D08.811.520.650.200 D12.644.360.050 D12.776.476.050
|
| Concept/Terms |
Adenylyl Cyclases- Adenylyl Cyclases
- Cyclases, Adenylyl
- Adenylate Cyclase
- Cyclase, Adenylate
- 3',5'-cyclic AMP Synthetase
- 3',5' cyclic AMP Synthetase
- AMP Synthetase, 3',5'-cyclic
- Synthetase, 3',5'-cyclic AMP
- Adenyl Cyclase
- Cyclase, Adenyl
- Adenylyl Cyclase
- Cyclase, Adenylyl
|
Below are MeSH descriptors whose meaning is more general than "Adenylyl Cyclases".
Below are MeSH descriptors whose meaning is more specific than "Adenylyl Cyclases".
This graph shows the total number of publications written about "Adenylyl Cyclases" by people in this website by year, and whether "Adenylyl Cyclases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 | | 1995 | 2 | 1 | 3 | | 1996 | 0 | 1 | 1 | | 1997 | 2 | 1 | 3 | | 1998 | 4 | 1 | 5 | | 1999 | 0 | 2 | 2 | | 2000 | 1 | 2 | 3 | | 2001 | 0 | 1 | 1 | | 2002 | 1 | 0 | 1 | | 2005 | 1 | 0 | 1 | | 2006 | 2 | 1 | 3 | | 2010 | 2 | 0 | 2 | | 2011 | 0 | 1 | 1 | | 2012 | 1 | 0 | 1 | | 2014 | 1 | 1 | 2 | | 2015 | 1 | 1 | 2 | | 2016 | 3 | 1 | 4 | | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Adenylyl Cyclases" by people in Profiles.
-
Sinnott-Armstrong N, Sousa IS, Laber S, Rendina-Ruedy E, Nitter Dankel SE, Ferreira T, Mellgren G, Karasik D, Rivas M, Pritchard J, Guntur AR, Cox RD, Lindgren CM, Hauner H, Sallari R, Rosen CJ, Hsu YH, Lander ES, Kiel DP, Claussnitzer M. A regulatory variant at 3q21.1 confers an increased pleiotropic risk for hyperglycemia and altered bone mineral density. Cell Metab. 2021 03 02; 33(3):615-628.e13.
-
Sayner SL, Choi CS, Maulucci ME, Ramila KC, Zhou C, Scruggs AK, Yarbrough T, Blair LA, King JA, Seifert R, Kaever V, Bauer NN. Extracellular vesicles: another compartment for the second messenger, cyclic adenosine monophosphate. Am J Physiol Lung Cell Mol Physiol. 2019 04 01; 316(4):L691-L700.
-
The E, Du P, Chang Y, Dai F, Wei C, Li J. Role of HSF1-upregulated AC6 in ameliorating heart failure in mice. Environ Toxicol Pharmacol. 2016 Oct; 47:79-85.
-
Ramos-Espiritu L, Diaz A, Nardin C, Saviola AJ, Shaw F, Plitt T, Yang X, Wolchok J, Pirog EC, Desman G, Sboner A, Zhang T, Xiang J, Merghoub T, Levin LR, Buck J, Zippin JH. The metabolic/pH sensor soluble adenylyl cyclase is a tumor suppressor protein. Oncotarget. 2016 Jul 19; 7(29):45597-45607.
-
Nakano SJ, Sucharov J, van Dusen R, Cecil M, Nunley K, Wickers S, Karimpur-Fard A, Stauffer BL, Miyamoto SD, Sucharov CC. Cardiac Adenylyl Cyclase and Phosphodiesterase Expression Profiles Vary by Age, Disease, and Chronic Phosphodiesterase Inhibitor Treatment. J Card Fail. 2017 Jan; 23(1):72-80.
-
Tardif JC, Rhainds D, Brodeur M, Feroz Zada Y, Fouodjio R, Provost S, Boul? M, Alem S, Gr?goire JC, L'Allier PL, Ibrahim R, Guertin MC, Mongrain I, Olsson AG, Schwartz GG, Rh?aume E, Dub? MP. Genotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation: Concordance With Clinical Outcomes. Circ Cardiovasc Genet. 2016 Aug; 9(4):340-8.
-
Antunes G, Roque AC, Simoes de Souza FM. Modelling intracellular competition for calcium: kinetic and thermodynamic control of different molecular modes of signal decoding. Sci Rep. 2016 Apr 01; 6:23730.
-
Whiteley AT, Pollock AJ, Portnoy DA. The PAMP c-di-AMP Is Essential for Listeria monocytogenes Growth in Rich but Not Minimal Media due to a Toxic Increase in (p)ppGpp. [corrected]. Cell Host Microbe. 2015 Jun 10; 17(6):788-98.
-
Tardif JC, Rh?aume E, Lemieux Perreault LP, Gr?goire JC, Feroz Zada Y, Asselin G, Provost S, Barhdadi A, Rhainds D, L'Allier PL, Ibrahim R, Upmanyu R, Niesor EJ, Benghozi R, Suchankova G, Laghrissi-Thode F, Guertin MC, Olsson AG, Mongrain I, Schwartz GG, Dub? MP. Pharmacogenomic determinants of the cardiovascular effects of dalcetrapib. Circ Cardiovasc Genet. 2015 Apr; 8(2):372-82.
-
Miyamoto SD, Stauffer BL, Polk J, Medway A, Friedrich M, Haubold K, Peterson V, Nunley K, Nelson P, Sobus R, Stenmark KR, Sucharov CC. Gene expression and ?-adrenergic signaling are altered in hypoplastic left heart syndrome. J Heart Lung Transplant. 2014 Aug; 33(8):785-93.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|